Woodline Partners’s Blueprint Medicines BPMC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | – | Sell |
|
|||||
|
2025
Q2 | $68.2M | Sell |
|
|||||
|
2025
Q1 | $47.9M | Buy |
|
|||||
|
2024
Q4 | $47.1M | Buy |
|
|||||
|
2024
Q3 | $42M | Sell |
|
|||||
|
2024
Q2 | $94.9M | Buy |
|
|||||
|
2024
Q1 | $78.5M | Buy |
|
|||||
|
2023
Q4 | $75.1M | Buy |
|
|||||
|
2023
Q3 | $30.2M | Buy |
|
|||||
|
2023
Q2 | $18.4M | Buy |
|
|||||
|
2023
Q1 | $4.74M | Sell |
|
|||||
|
2022
Q4 | $10.5M | Buy |
|
|||||
|
2022
Q3 | $6.15M | Sell |
|
|||||
|
2022
Q2 | $5.86M | Buy |
|
|||||
|
2022
Q1 | $1.59M | Sell |
|
|||||
|
2021
Q4 | $6.65M | Sell |
|
|||||
|
2021
Q3 | $17.7M | Buy |
|
|||||
|
2021
Q2 | $5.02M | Sell |
|
|||||
|
2021
Q1 | $8.64M | Buy |
|